<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001915'>Aplastic anemia</z:hpo> is a <z:e sem="disease" ids="C0005956" disease_type="Disease or Syndrome" abbrv="">bone marrow disease</z:e> characterized by marrow <z:mpath ids='MPATH_58'>aplasia</z:mpath> and <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Because hematopoietic stem cell transplantation (HSCT) cures severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA), it is the treatment of choice for younger patients </plain></SENT>
<SENT sid="2" pm="."><plain>For many years, antithymocyte globulin (ATG) has been standard immunosuppressive therapy for those <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> patients that have no HLA matched related donor </plain></SENT>
<SENT sid="3" pm="."><plain>ATG significantly improves <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> outcome, especially when combined with <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> (CSP) </plain></SENT>
<SENT sid="4" pm="."><plain>The response rate varies from 40% to 70% and long-term survival is comparable with patients receiving marrow transplant </plain></SENT>
<SENT sid="5" pm="."><plain>From 1983 until 2006, 46 SAA patients received HLA identical sibling marrow graft </plain></SENT>
<SENT sid="6" pm="."><plain>In the same period, 50 patients received standard immunosuppressive therapy combined from horse or rabbit ATG, 6 methyl <z:chebi fb="2" ids="8378">prednisolone</z:chebi> and <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Out of 46 transplant patients, 27 received a combination of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and thoraco-abdominal irradiation </plain></SENT>
<SENT sid="8" pm="."><plain>The overall probability of survival for SAA patients that underwent marrow grafting is 51%, and for patients receiving immunosuppressive treatment 20% </plain></SENT>
<SENT sid="9" pm="."><plain>We analyzed a cohort of patients receiving treatment after 1990 and found the probability of survival to be 64% for bone marrow transplanted patients and 36% for patients receiving immunosuppression </plain></SENT>
<SENT sid="10" pm="."><plain><z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">Infection</z:e> is the main cause of <z:hpo ids='HP_0011420'>death</z:hpo> in both groups </plain></SENT>
<SENT sid="11" pm="."><plain>In conclusion, we documented improving results using ATG in patients with SAA </plain></SENT>
</text></document>